JP2007505114A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505114A5
JP2007505114A5 JP2006526121A JP2006526121A JP2007505114A5 JP 2007505114 A5 JP2007505114 A5 JP 2007505114A5 JP 2006526121 A JP2006526121 A JP 2006526121A JP 2006526121 A JP2006526121 A JP 2006526121A JP 2007505114 A5 JP2007505114 A5 JP 2007505114A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
trifluoromethyl
alkoxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526121A
Other languages
English (en)
Other versions
JP2007505114A (ja
JP4897484B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/027533 external-priority patent/WO2005034850A2/en
Publication of JP2007505114A publication Critical patent/JP2007505114A/ja
Publication of JP2007505114A5 publication Critical patent/JP2007505114A5/ja
Application granted granted Critical
Publication of JP4897484B2 publication Critical patent/JP4897484B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (1)

  1. 式(I)
    Figure 2007505114
    Hetはピラゾール、イミダゾール、オキサゾール、トリアゾール、チアゾール、ピロール、フラン、又はチオフェンであり、
    XはO、S、NR5、又はCH2であり、
    R1は水素、ハロゲン、C1-6アルキル、トリフルオロメチル、又はフェニルであり、
    R2はC3-7シクロアルキル又はC5-12ブリッジされたビシクロアルキルであり、
    R3は水素、ハロゲン、C1-6アルキル、又はC1-6アルコキシであり、
    R4


    Figure 2007505114
    であり、
    R5は水素又はC1-6アルキルであり、
    R6は水素、メチル、又はOR5であり、
    R7はC1-6アルコキシ、シアノ、トリフルオロメチル、-CO2R5、-CONR9R10、SO2R5、又はSO2NR9R10であり、
    R8は水素、ハロゲン、C1-6アルキル、C1-6アルコキシ、シアノ、トリフルオロメチル、アセト、CO2R5、又はCONR9R10であり、
    R9及びR10は独立に水素、C1-6アルキル、-CH2CH2OHであり、又は
    NR9R10は一緒にされてピロリジン、ピペリジン、4-ヒドロキシピペリジン、ピペラジン、4-メチルピペラジン、モルホリン、又はチオモルホリンを形成し、かつ
    Ar1はハロゲン、C1-6アルキル、C1-6アルコキシ、シアノ、トリフルオロメチル、アセト、CO2R5、及びCONR9R10から選ばれた0-3個の置換基で置換されたチオフェン又はフェニルである〕
    の化合物又はこれらの化合物の医薬上許される塩もしくは溶媒和物。
JP2006526121A 2003-09-11 2004-08-24 C型肝炎ウイルスを治療するためのシクロアルキル複素環化合物 Expired - Fee Related JP4897484B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50206703P 2003-09-11 2003-09-11
US60/502,067 2003-09-11
PCT/US2004/027533 WO2005034850A2 (en) 2003-09-11 2004-08-24 Cycloalkyl heterocycles for treating hepatitis c virus

Publications (3)

Publication Number Publication Date
JP2007505114A JP2007505114A (ja) 2007-03-08
JP2007505114A5 true JP2007505114A5 (ja) 2007-10-11
JP4897484B2 JP4897484B2 (ja) 2012-03-14

Family

ID=34434839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526121A Expired - Fee Related JP4897484B2 (ja) 2003-09-11 2004-08-24 C型肝炎ウイルスを治療するためのシクロアルキル複素環化合物

Country Status (7)

Country Link
US (1) US7112601B2 (ja)
EP (1) EP1663105B1 (ja)
JP (1) JP4897484B2 (ja)
AT (1) ATE498398T1 (ja)
DE (1) DE602004031435D1 (ja)
ES (1) ES2358904T3 (ja)
WO (1) WO2005034850A2 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502258B1 (de) * 2005-07-22 2007-09-15 Univ Wien Cox-i-inhibitorverbindungen
US20070032488A1 (en) * 2005-08-05 2007-02-08 Genelabs Technologies, Inc. 6-Membered aryl and heteroaryl derivatives for treating viruses
RU2009109355A (ru) * 2006-08-17 2010-09-27 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Ингибиторы вырусной полимеразы
PL2144604T3 (pl) * 2007-02-28 2012-02-29 Conatus Pharmaceuticals Inc Sposoby leczenia przewlekłego zapalenia wątroby typu C z zastosowaniem RO 113-0830
WO2008106167A1 (en) * 2007-02-28 2008-09-04 Conatus Pharmaceuticals, Inc. Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
MX2009011930A (es) 2007-05-04 2009-11-18 Vertex Pharma Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
EP2193807A4 (en) 2007-08-24 2012-09-12 Univ Sapporo Medical BINDING PROTEIN AT CYCLOSPORIN A
CN101903351B (zh) 2007-12-19 2014-09-10 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
RU2011127080A (ru) 2009-01-07 2013-02-20 Сайнексис, Инк. Производное циклоспорина для применения в лечении заражения вирусом гепатита с и вич
EP2658859A4 (en) 2010-12-30 2014-07-30 Enanta Pharm Inc MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS
KR20140003521A (ko) 2010-12-30 2014-01-09 이난타 파마슈티칼스, 인코포레이티드 페난트리딘 매크로사이클릭 c형 간염 세린 프로테아제 억제제
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
US11724997B2 (en) 2018-03-01 2023-08-15 Annapurna Bio, Inc. Compounds and compositions for treating conditions associated with APJ receptor activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859642A2 (en) * 1995-10-17 1998-08-26 G.D. Searle & Co. Method of detecting cyclooxygenase-2
WO2000006529A1 (en) 1998-07-27 2000-02-10 Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. Diketoacid-derivatives as inhibitors of polymerases
CA2341970A1 (en) 1998-08-21 2000-03-02 Viropharma Incorporated Compounds, compositions and methods for treating or preventing viral infections and associated diseases
KR20010074949A (ko) 1998-09-04 2001-08-09 비로파마 인코포레이티드 바이러스성 감염 및 관련 질환의 치료 방법 또는 예방 방법
JP2002525295A (ja) 1998-09-25 2002-08-13 バイロファーマ・インコーポレイテッド ウイルス感染および関連疾患の治療または予防法
AU1324300A (en) * 1998-10-26 2000-05-15 Vertex Pharmaceuticals Incorporated Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase
US6566365B1 (en) 1999-11-04 2003-05-20 Biochem Pharma Inc. Method for the treatment of Flaviviridea viral infection using nucleoside analogues
AU763356C (en) 1999-12-27 2004-08-26 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP1256628A3 (en) 2001-05-10 2003-03-19 Agouron Pharmaceuticals, Inc. Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
PT1401825E (pt) 2001-06-11 2009-10-23 Virochem Pharma Inc Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
US6841566B2 (en) 2001-07-20 2005-01-11 Boehringer Ingelheim, Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
EP1429759A4 (en) * 2001-09-26 2004-12-15 Bristol Myers Squibb Co COMPOUNDS FOR TREATING HEPATITIS C VIRUS

Similar Documents

Publication Publication Date Title
JP2007505114A5 (ja)
JP2007508359A5 (ja)
RS20060316A (en) Derivatives of n-/heteroaryl(piperidine-2-yl)methyl/ benzamide, preparation method and application of same in therapeutics
JP2013517281A5 (ja)
JP2005523310A5 (ja)
JP2006508935A5 (ja)
RU2007134383A (ru) Производные 1,5-диарилпиррола, их получение и применение в терапии
JP2010539152A5 (ja)
WO2009010660A3 (fr) Indazoles substitues, leur preparation et leur utilisation en therapeutique
JP2007519695A5 (ja)
JP2006500348A5 (ja)
RU2011129383A (ru) Производное амина, обладающее антагостической активностью в отношении рецептора npy y5
JP2010504286A5 (ja)
JP2008513500A5 (ja)
JP2007519618A5 (ja)
PE20090297A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogenesis
CO6220851A2 (es) Compuestos de ciclohexandiona sustituidos en la posicion 5
JP2007518682A5 (ja)
CO6190582A2 (es) Derivados de heteroarilamida
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
ATE443701T1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
JP2008520637A5 (ja)
JP2009501745A5 (ja)
WO2008087611A3 (en) Pyrrolidine- and piperidine- bis-amide derivatives
JP2011512412A5 (ja)